RU2012121591A - Способ получения органических соединений - Google Patents

Способ получения органических соединений Download PDF

Info

Publication number
RU2012121591A
RU2012121591A RU2012121591/04A RU2012121591A RU2012121591A RU 2012121591 A RU2012121591 A RU 2012121591A RU 2012121591/04 A RU2012121591/04 A RU 2012121591/04A RU 2012121591 A RU2012121591 A RU 2012121591A RU 2012121591 A RU2012121591 A RU 2012121591A
Authority
RU
Russia
Prior art keywords
alkyl
alkoxy
halogen
formula
group
Prior art date
Application number
RU2012121591/04A
Other languages
English (en)
Russian (ru)
Inventor
Готтфрид ЗЕДЕЛЬМАЙЕР
Флориан Андреас РАМПФ
Доминик ГРИМЛЕ
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41716392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2012121591(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2012121591A publication Critical patent/RU2012121591A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
RU2012121591/04A 2009-10-27 2010-10-25 Способ получения органических соединений RU2012121591A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09174264.3 2009-10-27
EP09174264A EP2316821A1 (en) 2009-10-27 2009-10-27 Process for the manufacture of organic compounds
PCT/EP2010/066041 WO2011051213A1 (en) 2009-10-27 2010-10-25 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
RU2012121591A true RU2012121591A (ru) 2013-12-10

Family

ID=41716392

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012121591/04A RU2012121591A (ru) 2009-10-27 2010-10-25 Способ получения органических соединений

Country Status (24)

Country Link
US (1) US20120238761A1 (cg-RX-API-DMAC7.html)
EP (2) EP2316821A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013508436A (cg-RX-API-DMAC7.html)
KR (1) KR20120098652A (cg-RX-API-DMAC7.html)
CN (1) CN102596899A (cg-RX-API-DMAC7.html)
AR (1) AR079104A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010311636B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012009815A2 (cg-RX-API-DMAC7.html)
CA (1) CA2777031A1 (cg-RX-API-DMAC7.html)
CL (1) CL2012001081A1 (cg-RX-API-DMAC7.html)
CO (1) CO6531487A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP12011833A (cg-RX-API-DMAC7.html)
IL (1) IL219111A0 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN03032A (cg-RX-API-DMAC7.html)
MA (1) MA33692B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012005025A (cg-RX-API-DMAC7.html)
NZ (1) NZ599218A (cg-RX-API-DMAC7.html)
PE (1) PE20121501A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012500677A1 (cg-RX-API-DMAC7.html)
RU (1) RU2012121591A (cg-RX-API-DMAC7.html)
TN (1) TN2012000154A1 (cg-RX-API-DMAC7.html)
TW (1) TW201124389A (cg-RX-API-DMAC7.html)
WO (1) WO2011051213A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201202490B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321038B (zh) * 2011-07-11 2014-03-26 安徽省虹升生物科技有限公司 一种改进的制备缬沙坦方法
FR2981077B1 (fr) * 2011-10-11 2013-11-01 Michelin Soc Tech Methode pour preparer un melange maitre d'elastomere dienique et de silice
CN109641856B (zh) * 2016-09-02 2022-09-30 南京诺瑞特医药科技有限公司 缬沙坦二钠盐的晶型
CN110078640B (zh) * 2019-03-29 2022-04-05 浙江美诺华药物化学有限公司 一种缬沙坦中间体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE122007000050I1 (de) 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
ITMI20032267A1 (it) * 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
HRP20030965A2 (en) * 2003-11-24 2005-08-31 Belupo - Lijekovi I Kozmetika D.D. Process for production of (s)-n-pentanoyl-n-[[2'-(
US20060281801A1 (en) * 2005-04-19 2006-12-14 Ashok Kumar Process for the preparation of valsartan and its intermediates
CA2619955A1 (en) * 2005-08-22 2007-03-22 Alembic Limited Process for preparing valsartan
US7880015B2 (en) * 2006-07-03 2011-02-01 Aurobindo Pharma Ltd. Process for the preparation of angiotensin II antagonist
CN101450917B (zh) * 2007-12-06 2012-07-11 浙江海正药业股份有限公司 缬沙坦的合成方法
US7943794B2 (en) * 2008-02-13 2011-05-17 Ranbaxy Laboratories Limited Processes for the preparation of intermediates of valsartan

Also Published As

Publication number Publication date
IN2012DN03032A (cg-RX-API-DMAC7.html) 2015-07-31
KR20120098652A (ko) 2012-09-05
MX2012005025A (es) 2012-06-08
ECSP12011833A (es) 2012-06-29
JP2013508436A (ja) 2013-03-07
AU2010311636A1 (en) 2012-05-03
WO2011051213A1 (en) 2011-05-05
CA2777031A1 (en) 2011-05-05
AU2010311636B2 (en) 2014-03-06
MA33692B1 (fr) 2012-10-01
PH12012500677A1 (en) 2012-10-29
CO6531487A2 (es) 2012-09-28
NZ599218A (en) 2014-02-28
BR112012009815A2 (pt) 2016-10-18
IL219111A0 (en) 2012-06-28
EP2493848A1 (en) 2012-09-05
TW201124389A (en) 2011-07-16
ZA201202490B (en) 2012-12-27
PE20121501A1 (es) 2012-11-15
CN102596899A (zh) 2012-07-18
EP2316821A1 (en) 2011-05-04
TN2012000154A1 (en) 2013-12-12
US20120238761A1 (en) 2012-09-20
CL2012001081A1 (es) 2013-06-14
AR079104A1 (es) 2011-12-28

Similar Documents

Publication Publication Date Title
JP2024105360A5 (cg-RX-API-DMAC7.html)
RU2012121591A (ru) Способ получения органических соединений
EA201070874A1 (ru) Производные индол-2-карбоксамидов и азаиндол-2-карбоксамидов, замещённых силанильной группой, их получение и применение в терапии
AR068359A1 (es) Derivados de quinoleina sustituida, procesos para su preparacion e intermediarios de sintesis, una composicion fungicida que los comprende y un metodo para combatir o controlar hongos fitopatogenicos.
WO2009122044A3 (fr) Complexes de bore ou d'aluminium
RU2012148386A (ru) Способ получения 4-{4-[({[4-хлор-3-(трифторметил) фенил] амино}-карбонил) амино]-3-фторфенокси}-n-метилпиридин-2-карбоксамида, его солей и моногидрата
RU2013107770A (ru) Способ получения дронедарона
UA86013C2 (ru) Производные арилалкилкарбаматов, их получение и применение в лечении
RU2013133144A (ru) Цинкорганические комплексы, способы их получения и применение
RU2010136738A (ru) Ингибиторы для передачи сигнала брассиностероидов
WO2010128313A3 (en) Quaternary ammonium corrosion inhibitor
RU2010136996A (ru) Реакции сочетания, которые могут быть использованы при получении производных (1н-тетразол-5-ил)бифенила
RU2014129937A (ru) Способы и промежуточные соединения для получения фармацевтических агентов
JP2020502244A5 (cg-RX-API-DMAC7.html)
PE20070792A1 (es) Derivados lactama lactona como intermediarios en la sintesis de inhibidores de renina
Yan et al. Synthesis of sulfinamides via photocatalytic alkylation or arylation of sulfinylamine
RU2012142172A (ru) Азотсодержащее гетероциклическое соединение и способ его получения
JP2005538088A5 (cg-RX-API-DMAC7.html)
RU2015111236A (ru) Способ получения производного оксазола
RU2018100967A (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
RU2010115566A (ru) Ускоренное восстановление амидов и сложных эфиров аминоборанами и добавками
JP2019501877A5 (cg-RX-API-DMAC7.html)
RU2009143867A (ru) Способы получения производных n-изобутил-n-(2-гидрокси-3-амино-4-фенилбутил)-пара-нитробензолсульфониламида
JP2010111682A5 (cg-RX-API-DMAC7.html)
RU2015118752A (ru) Катализатор и способ его синтеза

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150202